Azure Biosystems 400 Imaging System

Azure Biosystems Imaging System

1.  This is a Combined Synopsis/Solicitation for Commercial Items prepared in accordance with the format in FAR Subpart 12.6 as supplemented with additional information included in this notice.  This announcement constitutes the only solicitation that will be issued; quotes are being requested and a written solicitation will not be issued. The Government anticipates a Firm-Fixed Price Purchase Order will be issued from this solicitation.

2. This requirement is being solicited as brand name only, small business set-aside, Request for Quotation (RFQ).  The RFQ number is RFQ-NIH-7000099

3. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2024-5, dated May 22, 2024.

4. This requirement is solicited as a small business set-aside.  The associated North American Industrial Classification System (NAICS) code for this procurement is 334516.  Its associated Small Business Size Standard is 1000 employees.

5. List of Item(s):  The vendor shall provide the Azure 400 Imagining System as  specified under Item 6. below.  Imaging systems must support Visible RGB Fluorescent imaging in three channels for Cy2/Cy3/Cy5 and similar dyes, Chemiluminescent blots, Bioluminescent samples, Chemiluminescent and Fluorescent protein arrays, Nucleic acid and protein gels, and True color imaging of opaque and translucid samples. Unit must enable EPI blue LED-based detection of SAFE dyes. Machine must have very compact dimension (42 cm x 56 cm x 33 cm) with integrated touchscreen computer to save valuable bench space.

6.  Description/Specifications of Requirements:

a.   Azure 400 Imaging System, Part # AZI400-01, 1 each

b.   Azure Trans White Table Bundle. Part #AZI1002, 1 each

c.  Applicable Shipping, Part #AZI1110, 1 fee

d.  Installation and Training for Azure Imaging System, Part #AZI1101, 1 each

e.  Additional 1-year Warranty - Azure 400, Part #AZI1115, 1 each

7.  Delivery:  Quote shall include the vendor’s delivery time after receipt of order to the National Institutes of Health, Bethesda, MD 20892.

52.252-1 Solicitation Provisions Incorporated by Reference (Feb 1998)

This RFQ incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available.  Also, the full text of a solicitation provision may be accessed electronically at this address:  www.acquisition.gov/far.

8. Provision 52.212-1 Instructions to Offerors – Commercial Items (Sept 2023) is incorporated by reference.

9. Provision 52.212-2 Evaluation – Commercial Items (Nov 2021) is incorporated by reference.

The provision 52.212-2 incorporated above is completed as follows.  Quotes received in response to this RFQ will be evaluated using the lowest-priced-technically-acceptable (LPTA) methodology.  To be determined “Technically Acceptable” the offeror must provide the item with the specifications listed under item 6. above.  The Government seeks the earliest delivery, therefore in addition to price, the most favorable delivery time may be considered to determine award.

10. Provision 52.212-3, Offeror Representations and Certifications – Commercial Items (May 2024) applies to this acquisition.

11. Clause at 52.212-4, Contract Terms and Conditions—Commercial Items (Nov 2023), applies to this acquisition and no addenda to the clause are included.

12. Clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders—Commercial Items (May 2024), applies to this acquisition.

13.  Quotes are due no later than 12:00 p.m. EST on Monday, July 22, 2024.  Send quotes via email in PDF format to Zetherine Gore at <zetherine.gore@nih.gov>.